Long-term enteral glutamine supplementation in very low birth weight infants: effects on growth parameters

Ayşe Korkmaz1, Murat Yurdakök, Sule Yiğit

  • 1Section of Neonatology, Department of Pediatrics, Hacettepe University, Faculty of Medicine, Ankara, Turkey.

Insights

Long-term enteral glutamine supplementation improved growth in very-low-birth-weight (VLBW) preterm infants. Supplemented infants showed significantly better weight, length, and circumference measurements by four months of age.

Area of Science:

  • Neonatal nutrition
  • Pediatric growth studies
  • Clinical nutrition research

Background:

  • Enteral and parenteral glutamine supplementation in preterm infants shows controversial benefits for neonatal outcomes.
  • Optimal nutritional strategies are crucial for the growth and development of very-low-birth-weight (VLBW) infants.

Purpose of the Study:

  • To investigate the impact of long-term enteral glutamine supplementation on growth parameters in VLBW preterm infants.
  • To determine if glutamine supplementation influences weight, length, and circumference measurements over a four-month period.

Main Methods:

  • A randomized controlled trial involving VLBW preterm infants (birth weight <= 1500 g).
  • Infants received either enteral glutamine (300 mg/kg/day) or placebo for 112 days (4 months).
  • Growth parameters including weight, length, head circumference, mid-arm circumference (MAC), and mid-thigh circumference (MTC) were measured monthly.

Main Results:

  • The glutamine-supplemented group (n=36) exhibited significantly higher mean weight, length, head circumference, MAC, and MTC compared to the placebo group (n=33) at four months.
  • These improvements in growth parameters were observed in VLBW infants receiving sustained enteral glutamine.

Conclusions:

  • Long-term enteral glutamine supplementation appears to promote significant improvements in overall growth in VLBW infants.
  • The positive effects on growth may manifest in a time-dependent manner, suggesting potential for sustained benefits.

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...